Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
... treat patients with non-reconstructable Critical limb
Ischemia (CLI) has completed enrollment . Sri ... University, Chennai, India.
ischemia is a persistent and relentless problem, ... mortality and morbidity. Prognosis of critical limb
ischemia is poor and no effective treatments have ...
Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities
... arm that allows those who have lost their limb
to perform tasks such as picking up a key, ... on an effort to provide fully integrated limb
replacements that enable victims of upper body limb
loss to perform arm and hand tasks with the ...
The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers
... the director of the University's Southern Arizona limb
Salvage Alliance (SALSA). "The problem is ... in the areas of diabetes and prevention of limb
amputations resulting from diabetic ulcers. Dr. ... at The University of Arizona's Southern Arizona limb
Salvage Alliance," said Oostur Raza, CEO, ...
Touch Bionics unveils innovative partner and reimbursement programs at AOPA
... to support patients with the
latest in upper limb
"The Partner Program is a key step ... Bionics' clinical
advocates, themselves upper limb
amputees, in interfacing with new patients
and ... to generate
interest among existing upper limb
patients, new patient contacts from
within their ...
New Liko Multiple Purpose Lifting Straps Facilitate Patient Care Tasks
... or problems with holding the
patient or limb
-- as well as time consuming. When used in ...
Typical applications include: -- limb
Lifting and Holding -- There are multiple ... units, the Multi-Strap Narrow can suspend a limb
with limited skin contact. For the initial ...
Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
... Mobilization Observed in Subjects with Critical limb
Ischemia Treated with ZFP ... most marked clinical improvements, as
judged by limb
salvage, ulcer healing, reduction in pain and ... 1 clinical trial in subjects
(n=20) with critical limb
ischemia (Rutherford Grade 4/5). ...
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
... knee. As lower extremity PVD worsens,
Ischemia (CLI) can develop, significantly increasing a
patient's risk for amputation and limb
loss. An estimated 1.5 - 2 million
patients ... which approximately 330,000
patients with lower limb
PVD are referred to surgery, either for ...
Sangamo BioSciences Reports Second Quarter 2008 Financial Results
... the trial to test an
additional dosing regimen.
-- Data from critical limb
ischemia Phase 1 trial presented at the
International Society for Cellular ... subjects who showed the most marked
clinical improvements, as judged by limb
salvage, ulcer healing, reduction
in pain and increased oxygen ...
Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb
... (LEU) is prevalent throughout the world and
poses a major threat to limb
integrity. Over 20 percent of all hospital
admissions in the US for ... who undergo LEA will
ultimately require an amputation of the opposite limb
within 5 years. The
estimated annual cost of care for treatment of lower ...
Touch Bionics acquires LIVINGSKIN
... CEO. "LIVINGKSIN provides the
world's most advanced cosmesis for upper limb
prosthetics and the i-LIMB
Hand is the world's most advanced upper limb
device. It's a perfect match.
The acquisition of LIVINGSKIN provides us ...
Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
... its angiogenesis
product candidate, Collategene, for treatment of critical limb
The treatment uses Vical technology to deliver a gene encoding ... the placebo
In the trial, 40 subjects with critical limb
peripheral arterial disease) were evaluated for ...
First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System
... in a number of conditions including deep vein thrombosis (DVT) and
ischemia. DVT affects approximately 2 million people in the U.S.
every year, and acute limb
ischemia affects over 250,000 people in the U.S.
Touch Bionics adds to sales, marketing, production and design teams
... booth 1117. A workshop presented by Touch Bionics
entitled "Bionic Upper limb
Technology Made Easy," workshop Number 32, will
take place on February 27, ... bionic technology from their practices and transform the
lives of upper limb
patients. For more information, please visit
Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
... booth 1117. A workshop presented by Touch
Bionics entitled "Bionic Upper limb
Technology Made Easy," workshop Number
32, will take place on February 27, ... bionic technology from their practices
and transform the lives of upper limb
patients. For more information,
please visit ...
Genzyme and Sunway to Collaborate on Gene Therapy Program in China
... form of peripheral arterial disease that often
leads to the need for limb
amputation. Genzyme previously completed a Phase
1 study of Ad2/HIF-1a involving patients with critical limb
ischemia. A Phase 3 development program would be funded equally by ...
FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
... deep vein thrombosis (DVT), when
large veins are blocked and acute limb
ischemia, when there is a sudden
decrease of blood flow to the arteries of ... affects approximately
2 million people in the U.S. every year, and acute limb
over 250,000 people in the U.S. every year. "Clearly, ...
LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
... opportunity to capture the significant market share in the bio-surgery area. The Company is changing the standard of care in three initial markets: limb
preservation, orthopedics, and shortly in ventral hernia repair. The addition of Pegasus underscores the increasingly diverse nature of our life ...
ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
... free mesh skin graft protection. Commenting on the new surgical technique, Dr. James Gleaves, FACS of Rush Hospital Wound Care, Hyperbaric and limb
Salvage Center, Meridian, Mississippi and co-author of two posters on the surgical procedure stated, "The development of a technique to cover and ...
AlloSource Distributes Record Amount of Tissue in 2008
... their families) that chose to be tissue donors, whose gifts we processed into allografts that helped people to walk again, live free from pain, avoid limb
amputation and survive devastating burns."
2008 accomplishments include:
Organic revenue growth of 21 percent as a result of ...
CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
... active lifestyle. In addition, cryopreserved allograft vascular tissues have enabled patients with impaired circulatory systems to avoid lower limb
"It has been very gratifying to be able to provide life-saving and life-enhancing tissues to so many patients over the years," ...
TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
... mobilizer TG-0054, is completing phase 1 trial in the US. TaiGen plans to develop TG-0054 for stem cell transplantation, chemosensitization, critical limb
ischemia and age-related macular degeneration. Nemonoxacin, a broad-spectrum non-fluorinated quinolone achieved the non-inferiority clinical cure ...
Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project
... direct costs savings of
GBP180,000 per year just from reducing waste with partially used vials.
Before CytoCare(TM), RSI [work-related upper limb
disorder] affected most of
our IV staff. At any given time we had at least one person resting and unable
to undertake this type of work, ...
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
... randomized to
one of two groups. The larger group was treated by intramuscular injection
of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb
months. The remaining group received an equal volume of placebo on the same
schedule. Each subject received a total of three treatments ...
Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
... - a unique global program to evaluate and reduce the
excess risk of myocardial infarction, stroke, kidney disease, loss of
vision and non-traumatic limb
amputation which exists in many patients with
heart disease and diabetes despite optimal, currently available care.
The R3i, a worldwide, academic, ...
Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008
... a unique global program to evaluate and to reduce the excess risk
of myocardial infarction, stroke, kidney disease, loss of vision and
amputation which exists in many patients with heart
disease and diabetes despite optimal, currently available care.
To address these important ...
Stenum Hospital Does its 600th American Disc Replacement Surgery
... available in the states, thousands of Americans are now heading to Germany, a worldwide technology leader, for breakthrough medical treatments. From limb
Transplants too Stem Cell Therapy, Germany is leading the way in the advancement of breakthrough medical procedures. One of these breakthroughs is ...
Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
... to restoring movement through neuroprosthetic devices, one that would link a person's brain to the activation of individual muscles in a paralyzed limb
to produce natural control and movements," said Joseph Pancrazio, Ph.D., a program director at the National Institute of Neurological Disorders and ...
Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008
... new data today representing an important preclinical
demonstration of the potential of PRT-201 to enhance outcomes in patients
suffering from lower limb
peripheral arterial disease (PAD). The
presentation, entitled, "Local Catheter-Directed Elastase Therapy: A Novel
Approach to Vessel Dilation and ...
Breakthrough in spinal injury treatment
... had dramatically different effects. One type of astrocyte called GDAsBMP was remarkably effective at promoting nerve regeneration and recovery of limb
motion when transplanted into spinal cord injuries. However, the other type of astrocyte cell generated called GDAsCNTF, not only failed to promote ...
US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
... fibromyalgia, diabetic neuropathy, neuropathic cancer pain, complex
regional pain syndrome, HIV/AIDS neuropathy, post-herpetic neuralgia,
pain, spinal cord injury, and trigeminal neuralgia). Insights
have also been added from WWMR's US Pain Clinic Monitor -- an audit of more
than 100 ...
Limbs saved by menstrual blood stem cells
... Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality were restored.
ischemia, an advanced form of peripheral artery disease, causes approximately 150,000 amputations per year in the US. Currently there are no medical ...
Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
... technology greatly assists in rescuing limbs which could not be treated by any other means. Opening an occluded artery is a must for saving the limb
from amputation. The CiTop(tm) Guidewire System is crossing these occlusions in tremendous ease even in the most complicated cases".
Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
... of chronic complete arterial blockage (CTO). These obstructions are hard to traverse and patients are therefore often referred to bypass surgery or limb
(PRWEB) July 9, 2008 -- Following the approval for CE Marking from the European Economic Area, Ovalum has ...
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
... clinical trials already underway, as well as the
practice of medicine, evaluating the use of adult stems cells to treat
indications such as critical limb
ischemia, coronary artery disease and
orthopedic conditions. We believe the collection of stem cells from bone
marrow could ultimately represent a ...
EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
... of peripheral vascular disease,
hemodialysis access, treatment of carotid and vertebral artery disease to
prevent stroke, diabetic foot problems, limb
salvage using endovascular
techniques and leg bypass surgery, and treatment and prevention of graft
stenosis. Dr. Mills has published over 130 ...
Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
... of new therapies will focus on the regeneration of bone,
muscle, tendon, nerve and blood vessels, as well as new methods for
transplantation of limb
and facial tissue and the treatment of burns.
Cleveland Clinic President and CEO Delos "Toby" Cosgrove has
experienced the devastation of war ...
Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
... five years that will focus on the
following five areas:
-- Burn repair -- Wound healing without scarring -- Craniofacial reconstruction -- limb
reconstruction, regeneration or transplantation -- Compartment syndrome, a condition related to inflammation after surgery or injury that can ...
Touch Bionics appoints Head of Clinical Advocacy
... of flexibility and dexterity previously unavailable to the patient,
Certified Prosthetist or Occupational Therapist working with upper
deficiencies. I look forward to being a member of the Touch
Bionics team and clinically supporting its revolutionary products to fellow
Biopure Announces 2008 First Quarter Financial Results
... results from five patients were sufficient to show a trend toward
proving the principle being tested. A second safety trial, in patients
amputation was also ended in late 2007, primarily because
of slow enrollment caused by a protocol design that did not take into
account different ...
ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
... Platform targeted to
the processing of bone marrow. Our initial focus will be in the use of bone
marrow stem cells in the treatment of critical limb
ischemia and myocardial
ischemia. We are in the process of preparing a 510 (k) submission and CE
Separately, the Company ...